EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
15/09/2023
Voltar para busca
Dado oficial do USPTO
A DIVISION OF GENESIS CLINICAL DIAGNOSTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
50
Atualização mais recente
15/09/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
44
Data de depósito
02/01/2019
Data de registro
16/08/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/08/2022
Última transação
15/09/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2022-01-00
Primeiro uso no comércio
2022-01-00
Código do desenho
3
Tipo de titular
16
Localização do titular
Hamilton, NJ, US
Examinador
NEHMER, JASON ROBERT
Unidade examinadora
N30
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized term "GENESIS" below the phrase "A DIVISION OF" and above the phrase "CLINICAL DIAGNOSTICS" with a stylized depiction of a molecule consisting of fourteen spheres representing atoms that are connected by straight bands representing bonds wherein the letter "I" in "GENESIS" is represented by a vertical band connecting two atoms; the color maroon appears in the letter "GENES" and "S" in "GENESIS"; the colors beige and white appear in the fourteen spheres representing atoms; the color black appears in the phrases "A DIVISION OF" and "CLINICAL DIAGNOSTICS", in the letter "I" in "GENESIS" and in the straight lines representing bonds; the color white appears in the shading of the atom.
Titulares e representantes
Titulares
Medical Diagnostic Laboratories, LLC
Representantes
Christina E. Brule Heslin Rothenberg Farley & Mesiti P.C.
Classificação técnica
Classes Nice
Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 44
Medical diagnostic testing, namely, infectious disease diagnosis through molecular based polymerase chain reaction testing for viral, fungal and bacterial infections, genetic testing by DNA analysis to detect gene mutations associated with the inherited susceptibility to cancer and to identify gene variants to predict the efficacy of certain drugs in a patient to treat a patient's disease or condition
Publicações
Histórico de despachos e eventos da marca no USPTO.
50 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/09/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/09/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/09/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
16/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
16/08/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/07/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/07/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
30/06/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
30/06/2022
IUAF
USE AMENDMENT FILED
10/06/2022
EISU
TEAS STATEMENT OF USE RECEIVED
10/06/2022
DOCK
ASSIGNED TO EXAMINER
28/01/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
28/12/2021
TMBN
TTAB RELEASE CASE TO TRADEMARKS
16/11/2021
OP.T
OPPOSITION TERMINATED NO. 999999
16/11/2021
OP.D
OPPOSITION DISMISSED NO. 999999
16/11/2021
EXPT
EXPARTE APPEAL TERMINATED
05/03/2021
OP.I
OPPOSITION INSTITUTED NO. 999999
23/11/2020
OPPF
OPPOSITION PAPERS RECEIVED AT TTAB
23/11/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/11/2020
PUBO
PUBLISHED FOR OPPOSITION
10/11/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/10/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/09/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
15/09/2020
EXPI
EX PARTE APPEAL-INSTITUTED
15/09/2020
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
15/09/2020
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
15/09/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
29/04/2020
GNFR
FINAL REFUSAL E-MAILED
29/04/2020
CNFR
FINAL REFUSAL WRITTEN
29/04/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/04/2020
ALIE
ASSIGNED TO LIE
06/04/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/09/2019
GNSL
LETTER OF SUSPENSION E-MAILED
09/09/2019
CNSL
SUSPENSION LETTER WRITTEN
09/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/09/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/09/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/08/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/08/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/03/2019
GNRT
NON-FINAL ACTION E-MAILED
26/03/2019
CNRT
NON-FINAL ACTION WRITTEN
26/03/2019
DOCK
ASSIGNED TO EXAMINER
20/03/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
24/01/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/01/2019
NWAP
NEW APPLICATION ENTERED
05/01/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace A DIVISION OF GENESIS CLINICAL DIAGNOSTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.